Longevity.Technology (@LongevityTech)· LongevityTech·· 16 天前评分8
Coya Therapeutics ALS试验入组达100例
Coya Therapeutics hits its 100th ALS trial enrollment and publishes new preclinical data, both pointing to the same immune-cell mechanism.
导读
Coya Therapeutics 达成第100例ALS试验入组，并发布新的临床前数据，两者均指向同一免疫细胞机制。 https://vist.ly/5k556 #longevity #geroscience #ALS #immunecells #preclinical
来源：Longevity.Technology (@LongevityTech) · x.com